Participants without a PD diagnosis, were divided into preclinical LRRK2 PD (UPDRS III <5) or prodromal LRRK2 PD (UPDRS III 5–10) based on the UPDRS part III score, as seen above. The gene discussed is LRRK2; the disease is Parkinson disease.